Search hospitals > Florida > Fort Myers
Florida Cancer Specialists
Claim this profileFort Myers, Florida 33901
Global Leader in Breast Cancer
Global Leader in Lung Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Cancer
Conducts research for Tumors
184 reported clinical trials
10 medical researchers
Summary
Florida Cancer Specialists is a medical facility located in Fort Myers, Florida. This center is recognized for care of Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Cancer, Tumors and other specialties. Florida Cancer Specialists is involved with conducting 184 clinical trials across 107 conditions. There are 10 research doctors associated with this hospital, such as Fadi Kayali, MD, Ivor J Percent, Lowell L Hart, and Vance M. Wright-Browne.Area of expertise
1Breast Cancer
Global LeaderStage IV
Stage III
HER2 negative
2Lung Cancer
Global LeaderStage IV
Stage III
BRAF positive
Top PIs
Fadi Kayali, MDFlorida Cancer Specialists South / Sarah Cannon Research Institute4 years of reported clinical research
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
13 reported clinical trials
38 drugs studied
Ivor J PercentFlorida Cancer Specialists - South Region6 years of reported clinical research
Studies Non-Small Cell Lung Cancer
Studies Lung Cancer
6 reported clinical trials
12 drugs studied
Lowell L HartWake Forest Baptist Medical Center / Wake Forest University4 years of reported clinical research
Studies Non-Small Cell Lung Cancer
Studies Breast Cancer
6 reported clinical trials
15 drugs studied
Vance M. Wright-BrowneFlorida Cancer Specialists4 years of reported clinical research
Studies Breast Cancer
Studies Cancer
6 reported clinical trials
11 drugs studied
Clinical Trials running at Florida Cancer Specialists
Breast Cancer
Non-Small Cell Lung Cancer
Follicular Lymphoma
Lymphoma
Cancer
Pancreatic Cancer
Head and Neck Squamous Cell Carcinoma
Ovarian Cancer
Head and Neck Cancers
PD-L1 Negative
Sacituzumab Govitecan
for Triple-Negative Breast Cancer
This trial is testing a drug called sacituzumab govitecan-hziy, which targets and kills cancer cells. It focuses on patients with advanced triple-negative breast cancer who have limited treatment options. The drug works by attaching to cancer cells and releasing a substance that kills them. Sacituzumab govitecan-hziy is an FDA-approved treatment for metastatic triple-negative breast cancer, especially for patients who have already tried other treatments.
Recruiting4 awards Phase 3
Sacituzumab Govitecan + Pembrolizumab
for Triple-Negative Breast Cancer
This trial compares the effectiveness of a combination of two drugs, SG and pembrolizumab, in patients with advanced triple-negative breast cancer. SG targets and kills cancer cells with chemotherapy, while pembrolizumab helps the immune system attack the cancer. Pembrolizumab has been shown to improve survival in various cancers, including triple-negative breast cancer, when used alone or in combination with other treatments.
Recruiting4 awards Phase 3
CAB-ROR2-ADC + PD-1 Inhibitor
for Breast Cancer
This trial is testing a new targeted cancer treatment called CAB-ROR2-ADC in patients with advanced solid tumors. The drug seeks out cancer cells with a specific marker and delivers a potent treatment directly to them.
Recruiting1 award Phase 1 & 29 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Florida Cancer Specialists?
Florida Cancer Specialists is a medical facility located in Fort Myers, Florida. This center is recognized for care of Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Cancer, Tumors and other specialties. Florida Cancer Specialists is involved with conducting 184 clinical trials across 107 conditions. There are 10 research doctors associated with this hospital, such as Fadi Kayali, MD, Ivor J Percent, Lowell L Hart, and Vance M. Wright-Browne.